SARS-CoV-2-IN-31
Modify Date: 2025-08-23 09:07:15
SARS-CoV-2-IN-31 structure
|
Common Name | SARS-CoV-2-IN-31 | ||
|---|---|---|---|---|
| CAS Number | 1017691-52-9 | Molecular Weight | 464.56 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C29H28N4O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SARS-CoV-2-IN-31SARS-CoV-2-IN-31 is an effective COVID-19 inhibitor. SARS-CoV-2-IN-31 exhibits excellent to mild activity against various cancer cell lines with IC50 values range from 28.84 to 38.36 μM. SARS-CoV-2-IN-31 can be used for the research of cancer[1]. |
| Name | SARS-CoV-2-IN-31 |
|---|
| Description | SARS-CoV-2-IN-31 is an effective COVID-19 inhibitor. SARS-CoV-2-IN-31 exhibits excellent to mild activity against various cancer cell lines with IC50 values range from 28.84 to 38.36 μM. SARS-CoV-2-IN-31 can be used for the research of cancer[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 38.36 μM (MCF-7); 38.46 μM (MDA-MB-231); 28.84 μM (HeLa); 30.62 μM (PC-3); ＞40 μM (Ishikawa)[1] |
| In Vitro | SARS-CoV-2-IN-31 exhibits antiproliferative activity in five different human cancer cell lines with IC50 values of 38.36 μM (MCF-7), 38.46 μM (MDA-MB-231), 28.84 μM (HeLa), 30.62 μM (PC-3) and ＞40 μM (Ishikawa), respectively[1]. SARS-CoV-2-IN-31 shows comparatively high binding affinity with value of -8.3 Kcal/mole[1] |
| References |
| Molecular Formula | C29H28N4O2 |
|---|---|
| Molecular Weight | 464.56 |
| InChIKey | YPKXRSPBOUKQJN-UHFFFAOYSA-N |
| SMILES | CCc1ccc(C(c2c(C)[nH]n(-c3ccccc3)c2=O)c2c(C)[nH]n(-c3ccccc3)c2=O)cc1 |